VSIR and hepatocellular carcinoma: Zong et al. and Zhang et al. reported that VISTA expressed in TCs was a favorable prognostic factor in patients with high-grade serous ovarian cancer and hepatoma (Zhang et al. 2018; Zong et al. 2020b).